Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,198 | -9,573 | 250,670 | 262,330 | -85,230 |
| Depreciation Amortization | 740 | 393 | 35,020 | 39,950 | 46,860 |
| Accounts payable and accrued liabilities | 400 | 111 | N/A | N/A | N/A |
| Other Working Capital | 1,076 | -206 | 9,570 | -13,070 | 56,390 |
| Other Operating Activity | -311 | -244 | 68,040 | 47,210 | 45,300 |
| Operating Cash Flow | $-14,293 | $-9,518 | $363,300 | $336,420 | $63,320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -125 | -30 | -18,750 | -19,900 | -10,620 |
| Net Acquisitions | N/A | N/A | 0 | 0 | -190 |
| Other Investing Activity | 0 | 0 | 39,020 | -47,860 | -70,590 |
| Investing Cash Flow | $-125 | $-30 | $20,270 | $-67,760 | $-81,400 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,000 | 2,000 | N/A | N/A | N/A |
| Debt Repayment | -1,189 | -821 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 10,484 | -103,290 | -163,600 | -23,780 |
| Financing Cash Flow | $10,811 | $11,663 | $-103,290 | $-163,600 | $-23,780 |
| Exchange Rate Effect | N/A | N/A | -2,440 | -40 | -420 |
| Beginning Cash Position | 4,705 | 2,590 | 247,050 | 142,040 | 184,330 |
| End Cash Position | 1,098 | 4,705 | 524,900 | 247,050 | 142,040 |
| Net Cash Flow | $-3,607 | $2,115 | $277,840 | $105,000 | $-42,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,293 | -9,518 | 363,300 | 336,420 | 63,320 |
| Capital Expenditure | -125 | -30 | N/A | N/A | N/A |
| Free Cash Flow | -14,418 | -9,548 | 363,300 | 336,420 | 63,320 |